FI862978A0 - Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö. - Google Patents

Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.

Info

Publication number
FI862978A0
FI862978A0 FI862978A FI862978A FI862978A0 FI 862978 A0 FI862978 A0 FI 862978A0 FI 862978 A FI862978 A FI 862978A FI 862978 A FI862978 A FI 862978A FI 862978 A0 FI862978 A0 FI 862978A0
Authority
FI
Finland
Prior art keywords
oncofetal
preparation
monoclonal antibodies
specific monoclonal
specific
Prior art date
Application number
FI862978A
Other languages
English (en)
Swedish (sv)
Other versions
FI92222B (fi
FI862978A (fi
FI92222C (fi
Inventor
Jr Joseph H Coggin
Jr William J Payne
Original Assignee
Univ South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Alabama filed Critical Univ South Alabama
Publication of FI862978A0 publication Critical patent/FI862978A0/fi
Publication of FI862978A publication Critical patent/FI862978A/fi
Publication of FI92222B publication Critical patent/FI92222B/fi
Application granted granted Critical
Publication of FI92222C publication Critical patent/FI92222C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI862978A 1984-11-21 1986-07-18 Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö. FI92222C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/673,794 US4686180A (en) 1984-11-21 1984-11-21 Onco-fetal specific monoclonal antibodies, methods of preparation and use
US67379484 1984-11-21
US8502258 1985-11-15
PCT/US1985/002258 WO1986003223A1 (en) 1984-11-21 1985-11-15 Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (4)

Publication Number Publication Date
FI862978A0 true FI862978A0 (fi) 1986-07-18
FI862978A FI862978A (fi) 1986-07-18
FI92222B FI92222B (fi) 1994-06-30
FI92222C FI92222C (fi) 1994-10-10

Family

ID=24704144

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862978A FI92222C (fi) 1984-11-21 1986-07-18 Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.

Country Status (9)

Country Link
US (1) US4686180A (fi)
EP (1) EP0203967B1 (fi)
JP (1) JPH0683666B2 (fi)
AU (1) AU593229B2 (fi)
CA (1) CA1307218C (fi)
DE (1) DE3583296D1 (fi)
FI (1) FI92222C (fi)
NO (1) NO170691C (fi)
WO (1) WO1986003223A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675287A (en) * 1984-07-26 1987-06-23 Scripps Clinic And Research Foundation Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) * 1984-10-01 1988-02-26 Centre Nat Rech Scient Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) * 1994-08-18 1996-03-05 Towa Kogyo Kk ボビン搬送用トレイ
US6335174B1 (en) 1996-04-05 2002-01-01 South Alabama Medical Science Foundation Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
DE10346627A1 (de) * 2003-10-08 2005-05-19 Weiss, Stefan, PD Dr. Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
US20070048795A1 (en) * 2005-08-26 2007-03-01 Xiangming Fang Immunoaffinity separation and analysis compositions and methods
EP4286410A1 (en) 2021-01-27 2023-12-06 Innovent Biologics (Suzhou) Co., Ltd. Single-domain antibody against cd16a and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440863A (en) * 1978-02-22 1984-04-03 Duke University Breast cyst fluid protein assay
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体

Also Published As

Publication number Publication date
EP0203967A1 (en) 1986-12-10
JPH0683666B2 (ja) 1994-10-26
NO170691B (no) 1992-08-10
NO170691C (no) 1992-11-18
EP0203967B1 (en) 1991-06-19
US4686180A (en) 1987-08-11
FI92222B (fi) 1994-06-30
AU5196486A (en) 1986-06-18
FI862978A (fi) 1986-07-18
NO862920L (no) 1986-07-18
CA1307218C (en) 1992-09-08
EP0203967A4 (en) 1987-04-10
DE3583296D1 (de) 1991-07-25
JPS62501189A (ja) 1987-05-14
NO862920D0 (no) 1986-07-18
AU593229B2 (en) 1990-02-08
FI92222C (fi) 1994-10-10
WO1986003223A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
DE68914244D1 (de) Monoklonaler Antikörper.
AU4493685A (en) Polyclonal antibodies, preparation and use
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
ZA852438B (en) Antibodies,manufacture and use
GB2185266B (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
NL189716C (nl) Diorganopolysiloxanen en werkwijze ter bereiding daarvan.
DE3885355D1 (de) Monoklonale Antikörper.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
FI862978A0 (fi) Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
DK188185D0 (da) Monoklonalt antistof
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
DE3583341D1 (de) Leberwurm-antigene.
DK105085D0 (da) Monoklonalt antistof samt hybridom-cellelinie, der udskiller dette
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
DK144485A (da) Monoklonale antistoffer
IT8422159A0 (it) 16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione.
DK37785A (da) Monoclonalt antistof
MX3601A (es) Anticuerpos monoclonales contra glicoproteinas asociadas a tumores, procedimiento para su preparacion y empleo
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
NO873488D0 (no) Monoklonale antistoffer.
NO890116D0 (no) Monoklonale antistoffer.
DE3689183D1 (de) Monoklonaler Antiasialo-GM1-Antikörper.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION